Food and Drug Policy Forum

FDLI's Food and Drug Policy Forum provides a marketplace for the exchange of policy ideas regarding food and drug law issues, and is complimentary to all FDLI Members. Policy Forum articles are on cutting-edge state, national and international policy issues related to food and drug law.


The Policy Forum is published biweekly (24 times a year) and is provided as a complimentary benefit to FDLI members, and by subscription to non-members. Individual issues of the Policy Forum are also available for separate purchase.



Food and Drug Policy Forum

Should FDA Assume Sole Enforcement Responsibility for Alleged Violations of the FDCA? Lessons from Recent Medical Device Enforcement and Qui Tam Cases

November 2014

Volume 4 Issue 11 of the FDLI Policy Forum – Medical Device Enforcement Actions  Issue 11 of the FDLI Food and Drug Policy For...

Post-Market Drug Regulation in the Age of Big Data: What Path to the Promised Land?

November 2014

Issue 10 of the FDLI Food and Drug Policy Forum, entitled “Post-Market Drug Regulation in the Age of Big Data: What Path to the Pro...

A Natural Solution: Why Should FDA Define “Natural” Foods?

September 2014

Issue 9 of the FDLI Policy Forum, entitled “A Natural Solution: Why Should FDA Define “Natural” Foods?” focuses o...

Biosimilar Nomenclature: Can we Achieve the Truth, the Whole Truth, & Nothing but the Truth?

September 2014

Issue 8 of the FDLI Policy Forum, written by Peter Pitts, focuses on biosimilar nomenclature and recommends that FDA require differential...

The GRAS Exemption and GRAS Notification: Is There a Need for Significant Changes to Current Policy?

August 2014

Volume 4 Issue 7 of the FDLI Policy Forum – GRAS Issue 7 of the FDLI Policy Forum focuses on the generally recognized as safe (GRAS...

Additional Policy Forum Details

The Policy Forum welcomes articles on cutting-edge state, national and international policy issues related to food and drug law. FDLI's Food and Drug Policy Forum is designed to provide a venue for the presentation of information, analysis and policy recommendations in the following areas: food, drugs, animal drugs, biologics, cosmetics, diagnostics, dietary supplements, medical devices and tobacco.

Each peer-reviewed issue of the Policy Forum presents an important policy topic in the form of a question, provides background information and detailed discussion of the issues involved in that policy question, details the relevant research, cites pertinent sources, and then makes policy recommendations.

The 23-member Food and Drug Policy Forum Editorial Advisory Board, comprised of 9 leading associations and 14 individuals involved in food and drug law issues, provides peer review and guidance on articles considered for publication in the Forum.

  • Center for Medicine in the Public Interest
  • Drug Information Association
  • Environmental Working Group
  • Food Marketing Institute
  • Medical Device Manufacturers Association
  • The Pew Charitable Trusts
  • PhRMA
  • Plasma Protein Therapeutics Association
  • United Fresh Produce Association